newsfilter
← Latest News
Business Wire·

Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced that management will host a webcast and